Mingwei Fu

867 total citations · 1 hit paper
35 papers, 536 citations indexed

About

Mingwei Fu is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, Mingwei Fu has authored 35 papers receiving a total of 536 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Hematology, 8 papers in Molecular Biology and 7 papers in Genetics. Recurrent topics in Mingwei Fu's work include Lymphoma Diagnosis and Treatment (7 papers), Acute Lymphoblastic Leukemia research (6 papers) and Chronic Lymphocytic Leukemia Research (5 papers). Mingwei Fu is often cited by papers focused on Lymphoma Diagnosis and Treatment (7 papers), Acute Lymphoblastic Leukemia research (6 papers) and Chronic Lymphocytic Leukemia Research (5 papers). Mingwei Fu collaborates with scholars based in China, United States and Namibia. Mingwei Fu's co-authors include Qianqian Dong, An Chen, Lihe Lu, Yining Li, Jianyun Yan, Xiaoyu Liu, Zirong Lan, Yuanzhi Ye, Qingchun Liang and Jing‐Song Ou and has published in prestigious journals such as Blood, Free Radical Biology and Medicine and Kidney International.

In The Last Decade

Mingwei Fu

29 papers receiving 536 citations

Hit Papers

Repression of the antiporter SLC7A11/glutathione/glutathi... 2022 2026 2023 2024 2022 50 100 150 200

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mingwei Fu China 9 249 185 159 75 58 35 536
Zirong Lan China 8 229 0.9× 187 1.0× 158 1.0× 74 1.0× 60 1.0× 18 491
Yuanzhi Ye China 8 229 0.9× 187 1.0× 158 1.0× 74 1.0× 60 1.0× 18 491
Meng Dou China 12 282 1.1× 126 0.7× 200 1.3× 69 0.9× 53 0.9× 27 499
Wenqian Zhou China 12 370 1.5× 262 1.4× 208 1.3× 45 0.6× 59 1.0× 22 712
Fengxun Liu China 12 259 1.0× 124 0.7× 174 1.1× 108 1.4× 49 0.8× 22 486
Yunwen Yang China 15 216 0.9× 79 0.4× 100 0.6× 103 1.4× 34 0.6× 23 505
Rui Yan China 11 224 0.9× 46 0.2× 104 0.7× 62 0.8× 45 0.8× 36 446
Honglin Hu China 17 298 1.2× 82 0.4× 136 0.9× 99 1.3× 49 0.8× 37 610
Hidenori Moriyama Japan 14 290 1.2× 172 0.9× 92 0.6× 19 0.3× 100 1.7× 36 670
Miguel Fontecha‐Barriuso Spain 14 482 1.9× 180 1.0× 138 0.9× 277 3.7× 91 1.6× 23 932

Countries citing papers authored by Mingwei Fu

Since Specialization
Citations

This map shows the geographic impact of Mingwei Fu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mingwei Fu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mingwei Fu more than expected).

Fields of papers citing papers by Mingwei Fu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mingwei Fu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mingwei Fu. The network helps show where Mingwei Fu may publish in the future.

Co-authorship network of co-authors of Mingwei Fu

This figure shows the co-authorship network connecting the top 25 collaborators of Mingwei Fu. A scholar is included among the top collaborators of Mingwei Fu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mingwei Fu. Mingwei Fu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fu, Mingwei, Zirong Lan, Yuanzhi Ye, et al.. (2025). The metabolite alpha-ketoglutarate inhibits vascular calcification partially through modulation of the TET2/NLRP3 inflammasome signaling pathway. Kidney International. 108(2). 233–252. 2 indexed citations
2.
Yuan, Shasha, et al.. (2025). Physician-patient sex concordance and patient outcomes: Evidence from China. SSM - Population Health. 30. 101783–101783.
3.
Huang, Zhiqiang, et al.. (2025). Study on excitation effect of different combination modes of shear wave vibroseis. Acta Geophysica. 73(3). 2461–2476.
4.
Fu, Mingwei, Qian Yang, Yan Ma, et al.. (2025). Study on the Resolution Effect of Chiral Separation of Finerenone Using Different d-Tartaric Acid Derivatives. Crystal Growth & Design. 25(11). 3813–3825.
5.
Fu, Mingwei, et al.. (2024). Comparing Microcrystal Electron Diffraction (MicroED) and X-ray crystallography as methods for structure determination of Oseltamivir phosphate. Journal of Molecular Structure. 1308. 138085–138085. 4 indexed citations
6.
Fu, Mingwei, Yuanjiang Wang, Min Ge, et al.. (2024). Chemically induced degradation of PRC2 complex by EZH2-Targeted PROTACs via a Ubiquitin-Proteasome pathway. Bioorganic & Medicinal Chemistry Letters. 113. 129968–129968. 2 indexed citations
7.
Fu, Mingwei, et al.. (2024). Study of the Polymorphic Transformation Mechanism and Crystal Habits Control of Peramivir from Dihydrate to Trihydrate. Crystal Growth & Design. 24(19). 7936–7947. 3 indexed citations
8.
Liu, Huimin, Dandan Shan, Wenyang Huang, et al.. (2024). Gemcitabine‐based conditioning compared to BEAM/BEAC conditioning prior to autologous stem cell transplantation for non‐Hodgkin lymphoma: No difference in outcomes. Cancer Medicine. 13(2). e6965–e6965. 1 indexed citations
9.
Fu, Mingwei, et al.. (2023). Novel pharmaceutical salt and solvates of rebamipide: Preparations, structural analysis and properties. Journal of Molecular Structure. 1288. 135786–135786. 4 indexed citations
10.
Huang, Zhiqiang, et al.. (2023). Study on energy excitation effect and structure optimization of vibratory vibrator considering captured road. Advances in Mechanical Engineering. 15(7). 1 indexed citations
12.
Wang, Siyi, Li Li, Qingchun Liang, et al.. (2022). Deletion of SIRT6 in vascular smooth muscle cells facilitates vascular calcification via suppression of DNA damage repair. Journal of Molecular and Cellular Cardiology. 173. 154–168. 17 indexed citations
13.
Ye, Yuanzhi, An Chen, Li Li, et al.. (2022). Repression of the antiporter SLC7A11/glutathione/glutathione peroxidase 4 axis drives ferroptosis of vascular smooth muscle cells to facilitate vascular calcification. Kidney International. 102(6). 1259–1275. 238 indexed citations breakdown →
14.
Chen, An, Qingchun Liang, Qianqian Dong, et al.. (2021). Up-regulation of heme oxygenase-1 by celastrol alleviates oxidative stress and vascular calcification in chronic kidney disease. Free Radical Biology and Medicine. 172. 530–540. 44 indexed citations
15.
Deng, Shuhui, Weiwei Sui, Mingwei Fu, et al.. (2021). [Clinical Analysis of Patients with MGUS, Primary Light Chain Amyloidosis, Multiple Myeloma or Multiple Myeloma with Concurrent Amyloidosis].. Europe PMC (PubMed Central). 29(3). 812–818. 2 indexed citations
16.
Dong, Qianqian, Yanting Chen, Wantao Liu, et al.. (2020). 25-Hydroxycholesterol promotes vascular calcification via activation of endoplasmic reticulum stress. European Journal of Pharmacology. 880. 173165–173165. 25 indexed citations
17.
Yan, Yuting, Xiaoqi Qin, Lanting Liu, et al.. (2020). Clonal Phylogeny and Evolution of Critical Cytogenetic Aberrations in Multiple Myeloma at Single Cell Level. Blood. 136(Supplement 1). 43–44. 1 indexed citations
18.
Zou, Dehui, Wenyang Huang, Hong Liu, et al.. (2015). [Clinical analysis of 25 patients with aggressive peripheral T-cell lymphoma in advanced stage treated with autologous stem cell transplantation].. PubMed. 36(6). 455–9. 3 indexed citations
19.
Huang, Jing, Dehui Zou, Mingwei Fu, et al.. (2011). [Imatinib combined with modified hyper-CVAD/MA followed by allogeneic hematopoietic stem cell transplantation in CR1 as the front-line therapy for adult Ph(+) acute lymphoblastic leukemia].. PubMed. 32(10). 673–8. 1 indexed citations
20.
Mi, Yingchang, Mingwei Fu, Wenjuan Yu, et al.. (2009). Intensive induction chemotherapy with regimen containing intermediate dose cytarabine in the treatment of de novo acute myeloid leukemia. American Journal of Hematology. 84(7). 422–427. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026